How shorted is Corvus Pharmaceuticals, Inc. right now?

21.80% of Corvus Pharmaceuticals, Inc.'s (CRVS) shares outstanding were reported short for settlement date 31 Jul 2026, per FINRA's consolidated short interest report.

What does this number include?

FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.

Why does it only update twice a month?

US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.

Which funds are short?

US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.

How shorted is Corvus Pharmaceuticals, Inc.?

More shorted than 97% of the 2,877 ranked US companies

21.80%

of shares outstanding reported short · settlement date 31 Jul 2026

vs previous report: +0.30
5 reports (~10 weeks): −0.71

Embed this chart

Paste this snippet to embed the interactive chart. It updates with each FINRA report and keeps the source attribution. Preview

<iframe src="https://howshorted.com/embed/us/crvs/" width="100%" height="430" style="border:0" loading="lazy" title="Corvus Pharmaceuticals, Inc. short interest chart"></iframe>
<p>Source: FINRA data compiled by <a href="https://howshorted.com/us/company/crvs/">howshorted.com</a></p>

Cite this page

Short position data for Corvus Pharmaceuticals, Inc.: FINRA, compiled by howshorted.com, settlement date 31 Jul 2026. https://howshorted.com/us/company/crvs/

History

Settlement date	Short %	Change
31 Jul 2026	21.80%	+0.30
15 Jul 2026	21.50%	−0.91
30 Jun 2026	22.41%	+1.12
15 Jun 2026	21.29%	+0.66
29 May 2026	20.63%	−1.88
15 May 2026	22.51%	+0.62
30 Apr 2026	21.89%	+1.74
15 Apr 2026	20.15%	−0.03
31 Mar 2026	20.18%	+1.07
13 Mar 2026	19.11%	−2.33
27 Feb 2026	21.44%	+1.51
13 Feb 2026	19.93%	+0.28
30 Jan 2026	19.65%	+4.27
15 Jan 2026	15.38%	−0.44
31 Dec 2025	15.82%	+3.26
15 Dec 2025	12.56%	−0.58
28 Nov 2025	13.14%	−0.12
14 Nov 2025	13.26%	+1.14
31 Oct 2025	12.12%	+0.27
15 Oct 2025	11.85%	−1.70
30 Sep 2025	13.55%	+0.57
15 Sep 2025	12.98%	+0.10
29 Aug 2025	12.88%	+0.41
15 Aug 2025	12.47%	−0.43
31 Jul 2025	12.90%	–

Frequently asked questions

How shorted is Corvus Pharmaceuticals, Inc. right now?: 21.80% of Corvus Pharmaceuticals, Inc.'s (CRVS) shares outstanding were reported short for settlement date 31 Jul 2026, per FINRA's consolidated short interest report.
What does this number include?: FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.
Why does it only update twice a month?: US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.
Which funds are short?: US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.